• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing
  3. / Healthcare

Edwards Lifesciences Is Recovering From a Bearish Gap

However, more consolidation may be needed before the uptrend resumes.
By BRUCE KAMICH
Jan 11, 2017 | 08:34 AM EST
Stocks quotes in this article: EW

Edwards Lifesciences (EW) had a serious downside price gap in late October. Prices continued lower to an early December low and have since recovered not quite half of its late 2015 plunge.

Some of our indicators have improved and prices are almost ready to attempt to move into the gap (price void), but more consolidation may be needed to restore the former uptrend.

In this one-year daily bar chart of EW, above, we can see a strong rally for much of 2016, but then a significant selloff starting in October. In late October, EW gapped below the 50-day moving average line and the 200-day moving average line in one dramatic day. Volume was very heavy, as investors and traders sold aggressively.

The On-Balance-volume (OBV) went from an impressive uptrend to a tailspin lower. A belated bearish death cross of the 50-day and 200-day averages can be seen in early December. As prices continued to decline in November, two bullish divergences can be seen. Prices made lower lows in November, but the OBV line made equal lows and the 12-day momentum study made higher lows. These two bullish divergences may have contributed to the price improvement seen since early December.

In this three-year weekly chart of EW, above, we can see a long and impressive uptrend from early 2014 with prices rising four-fold. The 40-week moving average line did a great job in identifying and keeping one in a great rally. The slope of the 40-week average line is almost flat now, as prices approach the underside of the line.

The weekly OBV line had a positive slope until October 2016 and the October/November dip could be be "just a dip." The Moving Average Convergence Divergence (MACD) in the lower panel is narrowing towards a possible cover shorts buy signal or a buy signal coming from below the zero line.

Bottom line -- prices have recovered nicely, but they are not entirely "out of the woods." Prices could fail at the underside of the 200-day average or the 40-week average if there are longs above the market that are just waiting to get even. Some sort of near-term pullback would not be unexpected. A dip into the $95-$90 area on light volume might be good, and we could see if fresh buyers step in on the retracement.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are restricted from trading individual securities.

TAGS: Investing | U.S. Equity | Healthcare | Markets

More from Healthcare

There Are Market Bright Spots, but I View the July Rally as a Head Fake

Bret Jensen
Aug 3, 2022 10:30 AM EDT

It's hard to see stock valuations rising when inflation remains high and the economy appears headed for a recession if it isn't in one already.

A Recession Appears Inevitable, but There Are Still Places to Invest

Bret Jensen
Jul 27, 2022 10:30 AM EDT

A few homebuilders and healthcare stocks seem likely to hold up better than most of the market in a recession.

Change Healthcare Continues to Knock on a Breakout Level

Bruce Kamich
Jul 25, 2022 11:25 AM EDT

The CHNG chart is at an interesting juncture.

The Healing Process Begins for Cano Health

Bruce Kamich
Jul 21, 2022 1:30 PM EDT

Here's how to approach CANO as the shares have made a bottom formation.

With HCA Healthcare, I'm Getting Healthy Indications

Bruce Kamich
Jul 21, 2022 9:20 AM EDT

The healthcare provider is set to report earnings Friday.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 10:24 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    To Improve Your Trading and Investing, Spend More ...
  • 08:44 AM EDT PETER TCHIR

    CPI Beats Expectations, But Maybe Not the 'Whisper'?

    Slightly better-than-expected inflation across the...
  • 01:44 PM EDT STEPHEN GUILFOYLE

    This Holding Lights Up With Strong Earnings

    Check out the latest from TheStreet's Stocks Under...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login